ITMCTR2100004304招募中1 期
Study on innate immune Warburg response of Yupingfeng powder granules in repeated transplantation failure patients
Shanxi Maternal and Child Health Care Hospital0 个研究点开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 25 至 35(—)
- 性别
- Female
入选标准
- •1. Those who meet the diagnostic criteria of traditional Chinese and Western medicine;
- •2. Signed informed consent;
- •3. Routine semen of the man showed no abnormality.
- •4. Aged 25~35 years;
- •5. No history of drug allergy or immunomodulatory drugs;
- •6. Adhere to oral Chinese medicine treatment.
排除标准
- •1. Congenital malformed reproductive organs, endometrial polyps surgery, hydrosalpinx, etc.
- •2. Had endometriosis polycystic ovary syndrome such as endocrine system disease, endocrine related diseases such as diabetes and thyroid disease;
- •3. Patients with reproductive system infectious disease or in the acute phase of sexually transmitted diseases;
- •4. Cause infertility for chromosome abnormal or familial heredity disease;
- •5. Anticardiolipin antibodies, anti beta 2 glycoprotein antibody, antinuclear antibodies, antisperm antibody and anti endometrial antibody examination were positive;
- •6. Patients with cardiovascular disease and family history of infectious diseases such as tuberculosis;
- •7. Incorrect judgment of curative effect because of incomplete information or failure to take medicine as required;
- •8. Patients with no history of long-term use of drugs, no radioactive radiation, there is no history of trauma or drug allergy;
- •9. The male reproductive system and semen function are normal, and there is no maternal and child blood group mismatch
- •10. The patient had no bad habits such as smoking, taking drugs or drinking alcohol.
- •11. Suffer from mental illness or severe cardiovascular and cerebrovascular diseases.
研究者
相似试验
尚未招募
1 期
Research on the immune response level of Yiqi Zengmian Prescription after the third dose of inactivated COVID-19 vaccine--A multicenter, randomized, double-blind, placebo-parallel controlled clinical researchITMCTR2200005641Xiyuan Hospital, China Academy of Chinese Medical Sciences
尚未招募
不适用
Clinical efficacy and immune mechanism of yifeiyin in delaying TKI resistance in non-small cell lung cancernon-small cell lung cancerITMCTR2000003377Tongde Hospital of Zhejiang Province
已完成
2 期
Clinical trial of Ayurvedic Medicines in Patients with Asymptomatic and/or Mild Symptoms of COVID-19CTRI/2020/10/028537Shree Baidyanath Ayurved Bhawan Pvt Ltd92
已完成
不适用
Analysis of innate immunity responses in infectious diseases.To examine the modulation of Toll-like receptor 2 and CD64 on monocytes in various infectious diseasesJPRN-UMIN000002827Department of , Graduate School of Medicine, Nagasaki University, Japan500
尚未招募
不适用
The analysis of immune response on the effect of endocrine therapy in breast cancer patientsBreast cancerJPRN-UMIN000018621Juntendo University School of Medicine100
